Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicity

Elife. 2022 Mar 8:11:e73282. doi: 10.7554/eLife.73282.

Abstract

Natural killer (NK) cells play a crucial role in immunity, killing virally infected and cancerous cells. The balance of signals initiated upon engagement of activating and inhibitory NK receptors with cognate ligands determines killing or tolerance. Nevertheless, the molecular mechanisms regulating rapid NK cell discrimination between healthy and malignant cells in a heterogeneous tissue environment are incompletely understood. The SHP-1 tyrosine phosphatase is the central negative NK cell regulator that dephosphorylates key activating signaling proteins. Though the mechanism by which SHP-1 mediates NK cell inhibition has been partially elucidated, the pathways by which SHP-1 is itself regulated remain unclear. Here, we show that phosphorylation of SHP-1 in NK cells on the S591 residue by PKC-θ promotes the inhibited SHP-1 'folded' state. Silencing PKC-θ maintains SHP-1 in the active conformation, reduces NK cell activation and cytotoxicity, and promotes tumor progression in vivo. This study reveals a molecular pathway that sustains the NK cell activation threshold through suppression of SHP-1 activity.

Keywords: PKC; SHP-1; cancer; human; immunology; inflammation; natural killer; signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytotoxicity, Immunologic*
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Killer Cells, Natural
  • Phosphorylation
  • Protein Kinase C-theta / metabolism
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • Protein Tyrosine Phosphatases* / metabolism

Substances

  • Intracellular Signaling Peptides and Proteins
  • Protein Kinase C-theta
  • PTPN6 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • Protein Tyrosine Phosphatases

Grants and funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.